Gray Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Gray Wealth Management's ABBV Position: Q4 2024 in Review
Gray Wealth Management increased its AbbVie (ABBV) stake by 0.1% in Q4 2024, buying an estimated $735 and bringing the position to 4,130 shares worth $734K. The position accounts for 0.28% of the portfolio, ranked #53.
Gray Wealth Management first reported a position in ABBV in Q2 2020 and has held it in 19 quarters since. The position peaked at $815K in Q3 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.
- Gray Wealth Management held 4,130 shares of AbbVie worth $734K as of Q4 2024.
- Gray Wealth Management bought 4 AbbVie shares in Q4 2024, an estimated $735.
- AbbVie made up 0.28% of Gray Wealth Management's portfolio in Q4 2024, its #53 holding.
- Gray Wealth Management first reported a position in AbbVie in Q2 2020 and has held it in 19 quarters since.
- Gray Wealth Management's AbbVie position peaked at $815K in Q3 2024.
- 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.
Based on Gray Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.